AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL. [electronic resource]
- Gene therapy Nov 2005
- 1618-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't